Literature DB >> 18886154

A factor required for the growth of Leuconostoc citrovorum.

H E SAUBERLICH, C A BAUMANN.   

Abstract

Mesh：

Substances：

Year:  1948        PMID： 18886154

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  14 in total

1.  [THE SIGNIFICANCE OF THE FOLIC ACID METABOLISM FOR THE NORMAL AND PATHOLOGICAL MATURATION OF BLOOD CELLS].

Authors:  W WILMANNS; L JAENICKE
Journal:  Klin Wochenschr       Date:  1963-11-15

2.  [Determination, properties and significance of dihydrofolic acid reductase in the white blood cells in leukemia].

Authors:  W WILMANNS
Journal:  Klin Wochenschr       Date:  1962-05-15

3.  [Folic acid as a cofactor in biological reactions].

Authors:  L JAENICKE
Journal:  Experientia       Date:  1961-11-15

4.  Chemical and biological studies on 1, 2-dihydro-s-triazines. IX. Inhibition of synthesis of citrovorum factor in Leuconostoc citrovorum #8081 systems.

Authors:  G E FOLEY; E C HALEY
Journal:  Antonie Van Leeuwenhoek       Date:  1955       Impact factor: 2.271

5.  Chemical and biological studies on 1, 2-dihydro-s-triazines. VIII. Activity in nicotinic acid, riboflavin and thiamine systems.

Authors:  G E FOLEY; E C HALEY
Journal:  Antonie Van Leeuwenhoek       Date:  1955       Impact factor: 2.271

6.  Chemical and biological studies on 1, 2-dihydro-s-triazines. VII. Activity in pteroylglutamic acid-Lactobacillus casei #7469 systems.

Authors:  G E FOLEY; E C HALEY
Journal:  Antonie Van Leeuwenhoek       Date:  1955       Impact factor: 2.271

7.  Synthesis of a substance exhibiting citrovorum factor activity by Lactobacillus arabinosus 17-5.

Authors:  V B MITBANDER; A SREENIVASAN
Journal:  Arch Mikrobiol       Date:  1954

8.  Synthesis of a compound with folic acid activity by Lactobacillus arabinosus 17-5.

Authors:  V B MITBANDER; A SREENIVASAN
Journal:  Arch Mikrobiol       Date:  1954

9.  An evaluation of folic acid antagonists in adults with neoplastic diseases: a study of 93 patients with incurable neoplasms.

Authors:  J C WRIGHT; A PRIGOT; B WRIGHT; S WEINTRAUB; L T WRIGHT
Journal:  J Natl Med Assoc       Date:  1951-07       Impact factor: 1.798

10.  Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.

Authors:  Toshihiro Komura; Koh Miura; Tetsuhiko Shirasaka; Shinobu Ohnuma; Miki Shimada; Taiki Kajiwara; Fumiyoshi Fujishima; Alex Philchenkov; Kei Nakagawa; Katsuyoshi Kudoh; Sho Haneda; Masahide Toshima; Atsushi Kohyama; Hiroaki Musha; Takeshi Naitoh; Chikashi Shibata; Michiaki Unno
Journal:  Int J Clin Oncol       Date:  2014-05-08       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.